Publications by authors named "C Voltz"

Claim this Profile
H
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Sideroblasts or Beta-thalassemia.
Julio Delgado, Caroline Voltz, Milena Stain, Ewa Balkowiec-Iskra, Brigitte Mueller

Hemasphere· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease.
Julio Delgado, Caroline Voltz, Milena Stain, Tuomo Lapveteläinen, Susanne Urach

Hemasphere· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012.
Kim Pauwels, Isabelle Huys, Minne Casteels, Kristina Larsson, Caroline Voltz

Orphanet J Rare Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Relevance of fluoroquinolone use in Lorraine: results of the first survey].
T Doco-Lecompte, B Demoré, C Burty, G Rondelot, P Scheid, C Voltz

Med Mal Infect· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis